Načítá se...
Development and Validation of the PREMM(5) Model for Comprehensive Risk Assessment of Lynch Syndrome
PURPOSE: Current Lynch syndrome (LS) prediction models quantify the risk to an individual of carrying a pathogenic germline mutation in three mismatch repair (MMR) genes: MLH1, MSH2, and MSH6. We developed a new prediction model, PREMM(5), that incorporates the genes PMS2 and EPCAM to provide compre...
Uloženo v:
| Vydáno v: | J Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Clinical Oncology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5493047/ https://ncbi.nlm.nih.gov/pubmed/28489507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.69.6120 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|